It was discovered by Wheelock (1965) that T-cell mitogens induced interferon production in leukocyte cultures. He showed that this interferon (IFN) (now called interferon-y; for new nomenclature, see Interferon Nomenclature, 1980) was biochemically distinct from the interferons known at that time (now called IFN-tx and IFN-fl). Since then a great deal of effort has been put into the purification of IFN-)' (Langford et al., 1979; Wietzerbin et a/.,1979; Yip et al., 1981) . However, two main difficulties precluded progress analogous to that reached in the characterization of IFN-ct and -fl (Berthold et al., 1978; DeMaeyer-Guignard et al., 1978; Rubinstein et al., 1978) . First, the low titres of IFN-)' recovered from leukocyte cultures in response to mitogenic stimuli, and second, the observation that partially purified IFN-)' is quite unstable (W. E. Stewart II, personal communication) . In regard to the first point several laboratories have developed new methods of obtaining starting material of high activity. Some make use of mitogens like staphylococcal enterotoxin A (Langford et al., 1979) different from those currently used for T-cell activation. Others take advantage, in the human system, of a combined use of tumour promoters and phytohaemagglutinin (PHA) (Yip et al., 1981) .
We have previously reported (Marcucci et al., 1981) that murine T-cell clones continuously growing in T-cell growth factor-conditioned medium (TCGFCM) produced large amounts of IFN-)' in response to concanavalin A (Con A) or PHA, thus introducing a new possibility of starting purification of IFN-)' with material containing high titres of activity. However, the establishment of continuously growing T-cell clones is laborious and requires sterile conditions for long periods of time. In addition, since murine T-cell blasts from long-term lines adhere to plastic, it is necessary to set up large numbers of culture flasks, in order to obtain a sufficient quantity of material to start purification. In this report we describe a new technique, i.e. short-term culture of T cells in TCGFCM, that circumvents the problems raised by the previously described technique. The cells require a culture period of about 1 week and they grow in suspension, thus permitting a much higher recovery of interferon-containing supernatant per culture flask.
The mice used throughout this study were 8-to 12-week-old C57BL/6JBOM (B6) from G. J. Bomholtgard Ltd., Ry, Denmark. The following media were used. Complete Medium (CM): RPMI 1640 supplemented with 10% foetal calf serum (FCS), 2-mercaptoethanol (2-ME; 5 x 10-SM), glutamine (2 mM), penicillin-G (100 units/ml), streptomycin (100/~g/ml) (all reagents from Gibco; 2-ME from Fluka AG, Buchs, Switzerland). Normal Medium (NM): as CM, but with 2.5 % FCS and without 2-ME. TCGFCM: as CM but with 20 % (v/v) TCGF-containing supernatant. TCGF-containing supernatants were produced as described previously (Marcucci et al., 198 i) . Briefly, Sprague-Dawley (Zentralinstitut fiir Versuchstiere, Hannover, F.R.G.) rat spleen cells were adjusted to a concentration of 5 × 106/ml in RPMI 1640, 5% FCS, 5 × 10 -5 M-2-ME and stimulated with 5/~g/ml Con A (Pharmacia). After 24 h the cells were centrifuged, the supernatants collected, filter-sterilized and stored at --70 °C.
Mouse spleens were removed aseptically and minced in Hanks' balanced salt solution in loosely fitting Potter homogenizers to obtain a single cell suspension. The cells were centrifuged and the pellet was resuspended for 3 min at 4 °C in 3 ml 0.83 % NH,C1 plus 1 ml FCS in order to lyse erythrocytes. At the end of the treatment the cells were washed twice with NM and resuspended in NM or CM (see below). Cells thus obtained were either stimulated directly in NM at different cell densities with different concentrations of Con A or short-term cultures in TCGFCM were established as follows. Cells were adjusted to a concentration of 2 × 106/ml in CM, stimulated with Con A (2.5 #g/ml) in 75 cm 2 tissue culture flasks (3024 F Falcon) for 1 day at 37 °C. At this time point there were 0.7 × 106 to 1.2 × 106 residual living cells per ml. Cells were centrifuged, resuspended at a density of 0.25 x 106 cells/ml in TCGFCM and incubated for 2 days, when cells had reached a density of 1 × 106 to 1.5 x 106 cells/ml. They were readjusted to a density of 0.25 × 106 cells/ml in TCGFCM and incubated for another 2 days, when cells had reached a density of approx. 1 × 106 cells/ml. They were centrifuged, resuspended in NM and stimulated at different cell densities with different concentrations of Con A.
The cells were cultivated at 37 °C in Nunc 96-well plates. After 24 h the plates were centrifuged, the supernatants harvested and frozen at -70 °C. Interferon assays were performed as follows. Samples, serially diluted 1:3 in basal medium (BME) containing 2 % FCS, were put into the wells of a microtitre plate (3041 F, Falcon) containing confluent monolayers of L929 cells. After 18 to 20 h the medium was replaced by an appropriate dilution of vesicular stomatitis virus. Forty-eight h later the medium was discarded, the cells fixed with 4 % formaldehyde, washed exhaustively with water and finally stained with 0.5 % crystal violet. The titres were determined by estimation of the cytopathic effect and are given in laboratory units (U/ml). In our assay system 1 laboratory unit of IFN-ct/fl corresponds to 2 international reference units of IFN-a/fl (NIH standard G-002-904 511). Fig. 1 shows the titres of IFN-y activity produced by normal spleen cells, cultivated at different densities in response to different doses of Con A. As can be seen, IFN-~ was detectable at a density of 1 x 106 cells/ml and reached a maximum at 8 × 106 to 16 × 106 cells/ml. The optimal mitogen dose in these experiments was 2.5 #g/ml Con A for most concentrations. The data in Fig. 2 show the titres of IFN-~ produced by cells cultured for 4 days in TCGFCM in response to Con A. Compared to normal spleen cells, antiviral activity was detectable at a much lower cell density (1.5 × 104 to 3 × 104 cells/ml). Supernatants containing up to 5000 U/ml IFN-7 could be recovered by stimulation of these cells. The optimal mitogen dose was in most cases 10 #g/ml, considerably higher than for normal spleen cells. Cells cultured for only 2 days in TCGFCM were also tested for Con A-induced IFN-~ production and gave results intermediate between the titres obtained by stimulation of freshly isolated spleen cells and of cells cultured for 4 days in TCGFCM (data not shown).
The Con A-induced antiviral activity produced by spleen cells cultured for brief periods of time in TCGFCM fulfilled the criteria for it to be defined as IFN-?: it was pH 2-labile, trypsin-sensitive, RNase-insensitive, it did not protect human Wish cells and the titre was unaffected by centrifugation at 100000 g for 1 h. Furthermore, it had a distinct antigenic profile, in that it was not neutralized by an antiserum having anti-mouse IFN-a/fl activity (a generous gift of Dr E. DeMaeyer, Orsay, Paris; neutralizing titre of 1 : 25 000 against 10 U of antiviral activity). The activity, however, was lost after treatment with an antiserum having anti-mouse IFN-y activity (neutralizing titre of 1:128 against I0 U of antiviral activity; the biological properties of this antiserum will be described in detail elsewhere; P. Krammer, unpublished results). Complete biochemical characterization of IFN-y, either murine or human, has not been achieved as yet. This is in part due to the fact that only low titres of activity are obtained upon mitogen stimulation of normal leukocyte cultures. We have previously reported (Marcucci et al., 1981) that murine T-cell clones from long-term culture produce high titres of IFN-y upon stimulation with T-cell mitogens. Now we describe a considerably easier method to produce Short communications supernatants containing high titres of IFN-? activity. This method is based on restimulation with Con A of mitogen-activated murine spleen cells cultured for only brief periods of time in TCGFCM. The experimental procedure that we used was extremely simple: activation of spleen cells with Con A for 1 day in order to expose TCGF receptors on the cell surface, 4 days of culture in TCGFCM, resuspension of the ceils in NM and restimulation with Con A.
As can be seen by comparison of Fig. 1 and 2 , activated spleen cells cultured for brief periods of time in TCGFCM produced up to 20-fold more IFN than freshly isolated spleen cells in response to the same mitogen. This is best explained if we assume that by means of this culture technique the frequency of the producer cell of murine IFN-y, i.e. the T-cell and perhaps a particular subpopulation thereof, increases considerably. The optimal mitogen dose for IFN-y production by cells cultured for brief periods of time in TCGFCM was significantly higher than in normal spleen cell cultures at each cell density. We made a similar observation with T-cell clones from long-term cultures (Marcucci et al., 1981) . Probably the lectin receptors on the surface of cells cultured in TCGFCM undergo quantitative changes, thus requiring higher mitogen doses for activation.
In conclusion, the method described above permits the recovery of supernatants containing several thousand units/ml IFN-? and circumvents the problems raised by culture of T-cell clones for long periods of time.
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